Nebula Research & Development’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,933
Closed -$440K 934
2024
Q1
$440K Buy
+10,933
New +$440K 0.09% 404